ScienceDex / Researcher record
James Crapo
- National Jewish Health (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 5% Funded
- Early Career
NIH Funding · FY2026
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $9.3M in linked award amounts across 1 award record · Award-linked rank #974.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2026 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 80914201Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award records by amount
NIH award records listing James Crapo as a PI. Multi-PI records show the full award amount for context.
- 75N92023D00011-0-759802600001-1N01Contact PICOPD GENE - GENETIC EPIDEMIOLOGY OF COPD - TASK AREA A: YEAR 4 - AUGUST 10, 2026 - AUGUST 09, 2027$9.3Maward amount
Award organization
Organizations that administered FY2026 awards listing James Crapo as a PI.
FY2026 award administered by National Jewish Health (CO).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardNational Jewish Health
- 2026$500K Cumulative Funding
- 2026$1M Cumulative Funding
- 2026$2M Cumulative Funding
- 2026$5M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #974
- 2026Entered Top 25% NationallyRanked #974
- 2026Entered Top 10% NationallyRanked #974
- 2026Entered Top 5% NationallyRanked #974